NLS Science News

A new Uppsala University study shows that certain types of antibiotics can be linked to changes in the gut microbiome as long as four to eight years after treatment.

For decades, Duchenne muscular dystrophy was a diagnosis without effective treatment. Through pioneering work on RNA-based therapies that allow cells to bypass faulty genes, Muntoni helped demonstrate that even severe inherited diseases can be modified at their molecular source — a shift that reshaped genetic medicine.

Researchers at the University of Turku have discovered and characterised at the atomic level a mechanism that enables bacterial pathogens – including hospital bacteria Acinetobacter baumannii and Pseudomonas aeruginosa – to assemble antibiotic-resistant three-dimensional (3D) biofilms.

Data from Finnish and Swedish cohorts link specific RAS mutation subtypes to distinct treatment outcomes, strengthening the evidence base for biomarker‑guided therapy.

A 2026 population‑based cohort study covering Denmark, Finland, Iceland, Norway and Sweden analysed 1‑year relative survival and excess mortality in cancer patients diagnosed during March–December 2020 versus expectations from 2011–2019.

A Swedish–Norwegian research team has identified blood-based biomarkers that could flag Parkinson’s disease up to two decades before classic motor symptoms appear.